PubMed Health⌕ Search

Biomedical subjects

A Posner

Publications and source records attributed to A Posner.

17 recordsLinked to original sources
PubMed1996

Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis.

The cytoskeletal protein non-erythroid alpha-spectrin is well documented as an endogenous calpain substrate, especially under pathophysiological conditions. In cell necrosis (e.g. maitotoxin-treated neuroblastoma SH-SY5Y cells), alpha-spectrin breakdown products (SBDPs) of 150 kDa and 145 kDa were produced by cellular calpains. In contrast, in neuronal cells undergoing apoptosis (cerebellar granule neurons subjected to low potassium and SH-SY5Y cells treated with staurosporine), an additional SBDP of 120 kDa was also observed. The formation of the 120 kDa SBDP was insensitive to calpain inhibitors but was completely blocked by an interleukin 1 beta-converting-enzyme (ICE)-like protease inhibitor, Z-Asp-CH2OC(O)-2,6-dichlorobenzene. Autolytic activation of both calpain and the ICE homologue CPP32 was also observed in apoptotic cells. alpha-Spectrin can also be cleaved in vitro by purified calpains to produce the SBDP doublet of 150/145 kDa and by ICE and ICE homologues [ICH-1, ICH-2 and CPP32(beta)] to produce a 150 kDa SBDP. In addition, CPP32 and ICE also produced a 120 kDa SBDP. Furthermore inhibition of either ICE-like protease(s) or calpain protects both granule neurons and SH-SY5Y cells against apoptosis. Our results suggest that both protease families participate in the expression of neuronal apoptosis.

Amino Acid Sequence↗
PubMed1996

Phenytoin pretreatment prevents hypoxic-ischemic brain damage in neonatal rats.

This study was performed to investigate whether the anticonvulsant phenytoin has neuroprotective effect in a model of hypoxia-ischemia with neonatal rats. The left carotid artery of each rat was ligated, followed by 3 h of hypoxic exposure (8% O2) in a temperature-regulated environment (36 degrees C). Two weeks later, brain damage was assessed by measuring loss of brain hemisphere weight. Phenytoin had no effect on body temperature or plasma glucose, but attenuated brain damage in a dose-dependent manner (3, 10, and 30 mg/kg i.p.) when administered before the hypoxic episode. Phenytoin administered during or after hypoxia did not alter hypoxic brain damage significantly. A parallel experiment using histological examination of frozen brain sections demonstrated less brain infarction after phenytoin treatment (30 mg/kg i.p.). In an additional experiment measuring breakdown of an endogenous brain calpain substrate, spectrin, phenytoin treatment reduced this measure of early cellular damage. Our results indicate that pretreatment with phenytoin is neuroprotective at a plasma phenytoin concentration of approximately 12 micrograms/ml. These results are consistent with the hypothesis that blockade of voltage-dependent sodium channels reduces brain damage following ischemia.

Animals↗
PubMed1996

An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.

Overactivation of calcium-activated neutral protease (calpain) has been implicated in the pathophysiology of several degenerative conditions, including stroke, myocardial ischemia, neuromuscular degeneration, and cataract formation. Alpha-mercaptoacrylate derivatives (exemplified by PD150606), with potent and selective inhibitory actions against calpain, have been identified. PD150606 exhibits the following characteristics: (i) Ki values for mu- and m-calpains of 0.21 microM and 0.37 microM, respectively, (ii) high specificity for calpains relative to other proteases, (iii) uncompetitive inhibition with respect to substrate, and (iv) it does not shield calpain against inactivation by the active-site inhibitor trans-(epoxysuccinyl)-L-leucyl-amido-3-methylbutane, suggesting a nonactive site action for PD150606. The recombinant calcium-binding domain from each of the large or small subunits of mu-calpain was found to interact with PD150606. In low micromolar range, PD15O6O6 inhibited calpain activity in two intact cell systems. The neuroprotective effects of this class of compound were also demonstrated by the ability of PD150606 to attenuate hypoxic/hypoglycemic injury to cerebrocortical neurons in culture and excitotoxic injury to Purkinje cells in cerebellar slices.

Acrylates↗
PubMed1996

Total protein extraction from cultured cells for use in electrophoresis and western blotting.

Experimentation with cultured cells often requires analyzing cellular protein extract by gel electrophoresis and immunoblotting. Traditional methods for extracting cellular proteins by homogenization or detergent solubilization usually produce protein samples that are viscous (due to the presence of DNA) and prone to degradation due to the presence of endogenous protease activity. We have developed a method that involves solubilization of cells with sodium dodecyl sulfate (SDS), precipitation of proteins with trichloroacetic acid (TCA) with special physical exclusion of DNA aggregate and reconstitution of precipitated proteins with Tris base. Protein samples prepared by this method contain little DNA, making them ideal for long-term storage. The solubilized total protein extracts are fully compatible with protein assay, gel electrophoresis and Western blotting. When compared to protein extracts from a homogenization method, those from the TCA method showed an identical total protein staining pattern on SDS polyacrylamide gel electrophoresis and contained distinct cellular proteins recognized by many monoclonal and polyclonal antibodies tested (including anti-actin, spectrin, protein kinase C (alpha), talin and spectrin) on Western blots.

Actins↗
PubMed1995

Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents.

A zymographic assay for calpains in nondenaturing casein-containing polyacrylamide gels was developed. Calpain samples were run into the polyacrylamide gels by electrophoresis using a Tris-glycine buffer containing 1 mM EGTA to stabilize calpains. Upon completion of the electrophoresis, the gels were washed and incubated in a calpain activation buffer containing 1-4 mM calcium and 10 mM dithiothreitol for 20-24 h. After staining of the casein gels with Coomassie blue G250, both mu-calpain and m-calpain showed up as clearing bands. The amount of calpain loaded was proportional to the brightness of the clearing band. m-calpain can be easily distinguished from mu-calpain due to its higher mobility in the gel. Irreversible inhibitor (e.g., E64c) or tight-binding calmidazolium-treated mu-calpain remained inactive in the casein zymogram, whereas reversible inhibitor (e.g., calpain inhibitor I) was released from the protease by migration and dilution, lifting its inhibition. Crude homogenate of cultured cells (erythrocytes, Molt-4 and cerebrocortical neurons) or tissue (rat brain) can be directly analyzed for the presence of calpain isoforms despite the presence of endogenous calpastatin. Using this technique, mu-calpain activity in Molt-4 cells was found to decrease progressively with A23187 treatment, as a reflection of autolytic inactivation.

Animals↗
PubMed1995

Aurintricarboxylic acid is an inhibitor of mu- and m-calpain.

Aurintricarboxylic acid (ATA) is an endonuclease inhibitor which has been shown to block apoptotic cell death. We have now demonstrated that ATA is also an inhibitor of the Ca(2+)-activated neutral protease (calpain), a class of cytosolic enzyme that may also be activated during apoptosis. The two major calpain isoforms (mu- and m-calpain) were both inhibited by ATA with IC50's of 22 microM and 10 microM, respectively. The autolysis of purified mu-calpain was prevented by ATA in a concentration-dependent manner. Using casein zymography, it was found that the inhibition of mu-calpain by ATA was reversible. Finally, in a fetal rat cerebrocortical culture model of excitotoxicity, pre- and post-treatment of ATA (50 microM) reduced N-methyl-D-aspartate (NMDA)-induced spectrin breakdown and neuronal death, while application of ATA concurrent to NMDA challenge alone had no effect. This pattern of protection could not be explained by simple NMDA receptor antagonism. We thus propose that the neuroprotective effect of ATA could be in part due to its ability to inhibit calpain.

Amino Acid Sequence↗
PubMed1993

Problems in formulating method-insensitive proficiency testing materials.

Significant problems exist in formulating method-insensitive proficiency materials. Many steps are required in processing human plasma, and difficult choices are involved in the selection of appropriate materials to be added to the processed plasma. Additionally, analytes may vary widely in their recovery from method to method. To enhance understanding of the procedures and problems involved in the development and manufacture of proficiency materials, a number of constituents and their method-specific recoveries are reviewed.

Bias↗